Monday, December 7, 2020

Palantir wins a three-year deal worth $44.4M with the FDA to use Palantir software to power drug reviews and inspections, including possible COVID-19 treatments (Lizette Chapman/Bloomberg)

Lizette Chapman / Bloomberg:
Palantir wins a three-year deal worth $44.4M with the FDA to use Palantir software to power drug reviews and inspections, including possible COVID-19 treatments  —  Palantir Technologies Inc. won a deal with the U.S. Food and Drug Administration to help power drug reviews and inspections …



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

China's smartphone shipments fell 4.3% YoY to 66M units in Q2, the fifth consecutive quarter of decline, amid a memory shortage; Huawei and Apple grew shipments (Kiranjeet Kaur/IDC)

Kiranjeet Kaur / IDC : China's smartphone shipments fell 4.3% YoY to 66M units in Q2, the fifth consecutive quarter of decline, amid ...